Pages that link to "Q34667917"

The following pages link to Minocycline treatment ameliorates interferon-alpha- induced neurogenic defects and depression-like behaviors in mice. (Q34667917):

Displaying 29 items.

• Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation (Q26770754) (← links)
• Glia in the cytokine-mediated onset of depression: fine tuning the immune response (Q26798929) (← links)
• Kososan, a Kampo medicine, prevents a social avoidance behavior and attenuates neuroinflammation in socially defeated mice (Q29994851) (← links)
• The Central Nervous System and the Gut Microbiome. (Q36182979) (← links)
• Minocycline attenuates interferon-α-induced impairments in rat fear extinction (Q37054821) (← links)
• Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. (Q37310533) (← links)
• Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem (Q37310556) (← links)
• Paeoniflorin ameliorates interferon-alpha-induced neuroinflammation and depressive-like behaviors in mice (Q37702695) (← links)
• Type I interferon pathway in CNS homeostasis and neurological disorders. (Q39315038) (← links)
• Minocycline has anti-inflammatory effects and reduces cytotoxicity in an ex vivo spinal cord slice culture model of West Nile virus infection (Q40055010) (← links)
• Microglia: An Interface between the Loss of Neuroplasticity and Depression (Q41699494) (← links)
• Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial (Q47648526) (← links)
• Minocycline Directly Enhances the Self-Renewal of Adult Neural Precursor Cells. (Q47696179) (← links)
• Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial. (Q47704592) (← links)
• Therapeutic strategies for treatment of inflammation-related depression. (Q47785792) (← links)
• Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression (Q48048624) (← links)
• The Gut-Microglia Connection: Implications for Central Nervous System Diseases (Q57817925) (← links)
• Anti-inflammatory effects of minocycline are mediated by retinoid signaling (Q58706730) (← links)
• Hippocampal Mrp8/14 signaling plays a critical role in the manifestation of depressive-like behaviors in mice (Q58765641) (← links)
• Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression (Q58795504) (← links)
• Clemastine Alleviates Depressive-Like Behavior Through Reversing the Imbalance of Microglia-Related Pro-inflammatory State in Mouse Hippocampus (Q59335643) (← links)
• New neurons use Slit-Robo signaling to migrate through the glial meshwork and approach a lesion for functional regeneration (Q59789100) (← links)
• The antidepressant impact of minocycline in rodents: A systematic review and meta-analysis (Q61445632) (← links)
• Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner (Q90100478) (← links)
• PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers (Q90170194) (← links)
• Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer's disease (Q90263636) (← links)
• The Role of Inflammation in Depression and Fatigue (Q92405241) (← links)
• Microglial depletion and repopulation in brain slice culture normalizes sensitized proinflammatory signaling (Q92746370) (← links)
• Priming of microglia with IFN-γ impairs adult hippocampal neurogenesis and leads to depression-like behaviors and cognitive defects (Q97544706) (← links)